Showing results (51-60 of 67) with videos related to
Sort By:
Pageof 7
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2004
Mature human Langerhans cells derived from CD34+ hematopoietic progenitors stimulate greater cytolytic T lymphocyte activity in the absence of bioactive IL-12p70, by either single peptide presentation or cross-priming, than do dermal-interstitial or monocyte-derived dendritic cellsGudrun Ratzinger, Jan Baggers, Maria A de Cos, et al.Rhode Island Medical Journal (2013)|October 2, 2020
Enforcing the "4T": An In-Line Calculator for HIT Antibody Ordering in the Electronic Medical RecordAdam S Zayac, Ross W Hilliard, Adam J Olszewski, et al.Journal of Translational Medicine|June 21, 2013
Cellular immunotherapy for refractory hematological malignanciesJohn L Reagan, Loren D Fast, Howard Safran, et al.Journal of Cellular Physiology|January 16, 2019
Potential biomarkers to detect traumatic brain injury by the profiling of salivary extracellular vesiclesYan Cheng, Mandy Pereira, Neha Raukar, et al.Neural Regeneration Research|October 23, 2019
Inflammation-related gene expression profiles of salivary extracellular vesicles in patients with head traumaYan Cheng, Mandy Pereira, Neha P Raukar, et al.Journal of Oncology Practice|February 25, 2016
Clinical Trial Accrual Targeting Genomic Alterations After Next-Generation Sequencing at a Non-National Cancer Institute-Designated Cancer ProgramKalyan C Mantripragada, Adam J Olszewski, Andrew Schumacher, et al.Leukemia & Lymphoma|May 17, 2021
3D tissue engineered plasma cultures support leukemic proliferation and induces drug resistanceKinan Alhallak, Pilar de la Puente, Amanda Jeske, et al.Blood|August 24, 2021
Phase 1 study of oral azacitidine (CC-486) plus R-CHOP in previously untreated intermediate- to high-risk DLBCLPeter Martin, Nancy L Bartlett, Julio C Chavez, et al.Cancer|July 11, 2022
Seroconversion and outcomes after initial and booster COVID-19 vaccination in adults with hematologic malignanciesThomas A Ollila, Rebecca H Masel, John L Reagan, et al.Molecular Oncology|February 28, 2018
Overexpression of Tpl2 is linked to imatinib resistance and activation of MEK-ERK and NF-κB pathways in a model of chronic myeloid leukemiaAnna Chorzalska, Nagib Ahsan, R Shyama Prasad Rao, et al.Pageof 7